Creative Planning - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 129 filers reported holding CARA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.

Quarter-by-quarter ownership
Creative Planning ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$207,0000.0%9,620
+11.5%
0.00%0.0%
Q3 2018$207,000
-27.9%
8,628
-63.2%
0.00%0.0%
Q4 2017$287,000
-20.9%
23,418
-11.7%
0.00%
-50.0%
Q3 2017$363,000
-9.7%
26,510
+0.5%
0.00%0.0%
Q2 2017$402,000
+52.3%
26,390
+84.0%
0.00%
+100.0%
Q1 2017$264,000
+116.4%
14,340
+9.3%
0.00%0.0%
Q4 2016$122,000
+144.0%
13,125
+118.8%
0.00%
Q3 2016$50,0006,0000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,647,473$24,780,0002.96%
Chescapmanager LLC 1,160,392$10,861,0002.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,333,000$12,477,0001.60%
Altium Capital Management LP 193,000$1,806,0000.66%
DISCIPLINED GROWTH INVESTORS INC /MN 1,700,230$15,914,0000.44%
ALPINE WOODS CAPITAL INVESTORS, LLC 171,423$1,605,0000.22%
Lisanti Capital Growth, LLC 159,225$1,490,0000.20%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,529$679,0000.15%
PINNACLE ASSOCIATES LTD 705,367$6,602,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 2,500,000$23,400,0000.13%
View complete list of CARA THERAPEUTICS INC shareholders